These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4810077)

  • 1. Effect of cyanate on erythrocyte deformability.
    Durocher JR; Glader BE; Gaines LT; Conrad ME
    Blood; 1974 Feb; 43(2):277-80. PubMed ID: 4810077
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopreservation of cyanate-treated sickle erythrocytes.
    Castro O
    Cryobiology; 1982 Aug; 19(4):339-45. PubMed ID: 7116897
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyanate on erythrocyte membrane surface charge.
    Durocher JR; Glader BE; Conrad ME
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):249-51. PubMed ID: 4771566
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous survival of cyanate-treated cryopreserved sickle erythrocytes.
    Castro O; Rana SR; Poillon WN
    Am J Hematol; 1986 Apr; 21(4):409-13. PubMed ID: 3953559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.
    Jensen MC; Bunn HF; Halikas GC; Nathan DG
    Adv Exp Med Biol; 1972; 28():297-302. PubMed ID: 5085173
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of etidronate disodium on filterability of sickle cell erythrocytes.
    Van Duzee BF; Sunberg RJ; Benedict JJ
    J Pharm Sci; 1980 May; 69(5):599-600. PubMed ID: 6770074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyanate on sickling.
    May A; Bellingham AJ; Huehns ER; Beaven GH
    Lancet; 1972 Mar; 1(7752):658-61. PubMed ID: 4125163
    [No Abstract]   [Full Text] [Related]  

  • 11. Reticulocyte survival in sickle cell anemia: effect of cyanate.
    Alter BP; Kan YW; Nathan DG
    Blood; 1972 Nov; 40(5):733-9. PubMed ID: 5078929
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyanate and sickle-cell disease.
    Cerami A; Peterson CM
    Sci Am; 1975 Apr; 232(4):44-50. PubMed ID: 1114310
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of the development of cyanate as a drug in the treatment of sickle cell anemia.
    Cerami A
    Ann N Y Acad Sci; 1974 Nov; 241(0):538-44. PubMed ID: 4611307
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased life span and membrane damage of carbamylated erythrocytes in vitro.
    Lane TA; Burka ER
    Blood; 1976 Jun; 47(6):909-17. PubMed ID: 1276471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sodium cyanate on globin synthesis.
    Habib M; Watson V; Schwartz E
    Blood; 1973 May; 41(5):635-9. PubMed ID: 4694080
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of cyanate. I. General effects on experimental animals.
    Cerami A; Allen TA; Graziano JH; DeFuria FG; Manning JM; Gillette PN
    J Pharmacol Exp Ther; 1973 Jun; 185(3):653-66. PubMed ID: 4197279
    [No Abstract]   [Full Text] [Related]  

  • 20. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.